BIB
ProShares - Ultra Nasdaq Biotechnology
1W: +2.2%
1M: -11.4%
3M: -5.4%
YTD: -1.1%
1Y: +46.6%
3Y: +55.9%
5Y: -7.2%
$79.47
+0.74 (+0.93%)
After Hours: $79.48 (+0.02, +0.03%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$66M
Holdings258
Top 10 Wt32.8%
Beta1.40
% Profitable22%
Coverage70%
Portfolio Valuation
P/E24.5
P/B0.8
P/S6.0
EV/EBITDA15.6
P/FCF23.3
PEG1.31
Profitability & Returns
Gross Margin82.4%
Net Margin22.0%
ROE5.4%
ROA3.7%
ROIC7.8%
Div Yield0.63%
Leverage & Liquidity
Debt/Equity0.12
Debt/Assets0.10
Net Debt/EBITDA-10.3x
Interest Cov7.7x
Current Ratio6.76
Quick Ratio5.24
Growth (YoY)
Revenue+29.2%
Net Income+60.7%
EPS+64.9%
FCF+34.6%
EBITDA+61.8%
Rev CAGR 3Y+31.6%
Quality Scores
Piotroski F5.5
Altman Z10.47
IS Quality66.1
IS Overall59.3
IS Value43.6
Median P/E-4.5
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 258 | 69.6% | -4.0 |
| Other | 9 | 30.4% | — |
Smart Money Overlap
4 holdings with signals
Showing 50 of 267 holdings
· Page 1 of 6
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Net Other Assets (Liabilities) Private | — | 30.20% | $24.5M | 24,472,046 | — | — | — |
| 2 | GILEAD SCIENCES INC | GILD | 6.85% | $5.6M | 38,245 | 20.2 | $171.6B | Healthcare |
| 3 | VERTEX PHARMACEUTICALS INC | VRTX | 6.38% | $5.2M | 11,098 | 29.2 | $115.6B | Healthcare |
| 4 | AMGEN INC | AMGN | 6.30% | $5.1M | 13,933 | 24.7 | $190.8B | Healthcare |
| 5 | REGENERON PHARMACEUTICALS | REGN | 4.27% | $3.5M | 4,571 | 17.1 | $77.9B | Healthcare |
| 6 | ALNYLAM PHARMACEUTICALS INC | ALNY | 2.30% | $1.9M | 5,846 | 138.5 | $43.6B | Healthcare |
| 7 | INSMED INC | INSM | 1.68% | $1.4M | 9,437 | -24.8 | $32.0B | Healthcare |
| 8 | BIOGEN INC | BIIB | 1.47% | $1.2M | 6,492 | 21.5 | $27.8B | Healthcare |
| 9 | UNITED THERAPEUTICS CORP | UTHR | 1.26% | $1.0M | 1,904 | 18.0 | $23.7B | Healthcare |
| 10 | MODERNA INC | MRNA | 1.14% | $921,677 | 17,289 | -7.4 | $21.1B | Healthcare |
| 11 | ARGENX SE - ADR | ARGX | 1.12% | $905,147 | 1,287 | 37.8 | $43.1B | Healthcare |
| 12 | ROYALTY PHARMA PLC- CL A | RPRX | 1.08% | $871,751 | 18,910 | 26.3 | $20.1B | Healthcare |
| 13 | ROIVANT SCIENCES LTD | ROIV | 1.07% | $870,430 | 30,779 | -23.6 | $19.6B | Healthcare |
| 14 | REVOLUTION MEDICINES INC | RVMD | 1.05% | $846,945 | 8,555 | -15.8 | $18.7B | Healthcare |
| 15 | INCYTE CORP | INCY | 1.00% | $807,891 | 8,687 | 14.2 | $18.4B | Healthcare |
| 16 | ILLUMINA INC | ILMN | 1.00% | $806,452 | 6,761 | 22.7 | $19.3B | Healthcare |
| 17 | VIATRIS INC | VTRS | 0.85% | $688,632 | 50,972 | -4.4 | $15.5B | Healthcare |
| 18 | ASCENDIS PHARMA A/S - ADR | ASND | 0.77% | $627,926 | 2,718 | -51.5 | $13.6B | Healthcare |
| 19 | BRIDGEBIO PHARMA INC | BBIO | 0.75% | $605,744 | 8,528 | -19.4 | $13.9B | Healthcare |
| 20 | NEUROCRINE BIOSCIENCES INC | NBIX | 0.71% | $572,898 | 4,412 | 27.3 | $13.2B | Healthcare |
| 21 | MEDPACE HOLDINGS INC | MEDP | 0.70% | $565,689 | 1,247 | 29.3 | $13.2B | Healthcare |
| 22 | SUMMIT THERAPEUTICS INC | SMMT | 0.66% | $532,918 | 32,947 | -12.4 | $13.4B | Healthcare |
| 23 | IONIS PHARMACEUTICALS INC | IONS | 0.64% | $518,461 | 7,167 | -30.9 | $12.0B | Healthcare |
| 24 | SANOFI-ADR | SNY | 0.64% | $515,094 | 11,712 | 9.2 | $112.1B | Healthcare |
| 25 | GUARDANT HEALTH INC | GH | 0.62% | $499,106 | 5,725 | -26.8 | $11.4B | Healthcare |
| 26 | JAZZ PHARMACEUTICALS PLC | JAZZ | 0.60% | $489,452 | 2,689 | -32.4 | $11.6B | Healthcare |
| 27 | BIOMARIN PHARMACEUTICAL INC | BMRN | 0.60% | $488,270 | 8,502 | 30.6 | $10.7B | Healthcare |
| 28 | EXELIXIS INC | EXEL | 0.60% | $487,296 | 11,865 | 14.8 | $11.5B | Healthcare |
| 29 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.55% | $442,152 | 1,003 | -35.9 | $10.6B | Healthcare |
| 30 | BIONTECH SE-ADR | BNTX | 0.50% | $405,076 | 4,474 | -16.7 | $22.3B | Healthcare |
| 31 | BEONE MEDICINES LTD-ADR | ONC | 0.50% | $403,772 | 1,394 | 158.2 | $30.3B | Healthcare |
| 32 | TEMPUS AI INC-CL A | TEM | 0.48% | $389,181 | 7,649 | -33.3 | $8.1B | Healthcare |
| 33 | IMMUNITYBIO INC | IBRX | 0.44% | $357,882 | 43,591 | -22.7 | $8.3B | Healthcare |
| 34 | AXSOME THERAPEUTICS INC | AXSM | 0.44% | $353,011 | 2,231 | -44.7 | $8.3B | Healthcare |
| 35 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.43% | $344,794 | 6,010 | 42.1 | $8.5B | Healthcare |
| 36 | PRAXIS PRECISION MEDICINES I | PRAX | 0.42% | $337,635 | 1,107 | -23.1 | $6.6B | Healthcare |
| 37 | HALOZYME THERAPEUTICS INC | HALO | 0.41% | $334,629 | 5,205 | 23.5 | $7.5B | Healthcare |
| 38 | CYTOKINETICS INC | CYTK | 0.41% | $329,212 | 5,412 | -9.7 | $7.7B | Healthcare |
| 39 | VAXCYTE INC | PCVX | 0.40% | $322,151 | 5,792 | -9.9 | $8.0B | Healthcare |
| 40 | KRYSTAL BIOTECH INC | KRYS | 0.40% | $320,705 | 1,282 | 36.0 | $7.5B | Healthcare |
| 41 | ABIVAX SA-ADR | ABVX | 0.40% | $320,623 | 2,612 | -31.1 | $7.3B | Healthcare |
| 42 | NUVALENT INC-A | NUVL | 0.39% | $318,181 | 3,197 | -17.3 | $7.2B | Healthcare |
| 43 | ARCELLX INC | ACLX | 0.36% | $293,031 | 2,559 | -28.2 | $6.7B | Healthcare |
| 44 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.33% | $267,707 | 2,767 | -51.0 | $6.7B | Healthcare |
| 45 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.33% | $267,276 | 2,953 | -28.8 | $5.8B | Healthcare |
| 46 | KYMERA THERAPEUTICS INC | KYMR | 0.31% | $253,446 | 3,184 | -21.4 | $6.4B | Healthcare |
| 47 | COGENT BIOSCIENCES INC | COGT | 0.30% | $242,410 | 6,794 | -7.5 | $5.9B | Healthcare |
| 48 | CARIS LIFE SCIENCES INC | CAI | 0.29% | $237,858 | 12,486 | -455.8 | $5.2B | Healthcare |
| 49 | PTC THERAPEUTICS INC | PTCT | 0.29% | $237,087 | 3,554 | 7.9 | $5.5B | Healthcare |
| 50 | CG ONCOLOGY INC | CGON | 0.29% | $235,197 | 3,569 | -31.6 | $5.6B | Healthcare |